Local view for "http://purl.org/linkedpolitics/eu/plenary/2000-12-11-Speech-1-085"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2000-12-11"^^xsd:date2
dcterms:Is Part Of	lp_eu:Clinical trials of medicines for human use2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20001211.5.1-085"2
lpv:hasSubsequent	lp_eu:2000-12-11-Speech-1-0862
lpv:speaker	lp:Marie-Noëlle Lienemann2
lpv:spokenAs	vice-president; Parliament's Bureau (1999-07-20--2001-03-27)3 unknown; Parti socialiste (1999-07-20--2001-03-27)3 vice-president; European Parliament (1999-07-20--2001-03-27)3 member; Committee on the Environment, Public Health and Consumer Policy (1999-07-21--2001-03-27)3 substitute; ECON (1999-07-22--2001-03-27)3 member_of_the_bureau; PES (2000-03-08--2001-03-27)3
lpv:translated text	"The next item is the recommendation for second reading () on behalf of the Committee on the Environment, Public Health and Consumer Policy, concerning the common position adopted by the Council with a view to adopting a European Parliament and Council directive on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use [8878/1/2000 – C5-0424/2000 – 1997/0197(COD)] (rapporteur: Mr Liese)"@en1
lpv:unclassifiedMetadata	"President."1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph